Amylyx Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Amylyx Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 68.1M shares, a 1% increase year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 67.2M shares, a 14.9% increase from 2022.
  • Amylyx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 58.5M shares, a 788% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 68.1M +677K +1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 68M +791K +1.18% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 67.9M +1.14M +1.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 67.2M +8.74M +14.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 67.4M +8.88M +15.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 67.2M +8.96M +15.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 66.7M +15.1M +29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 58.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 58.5M +51.8M +766% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 58.3M +51.8M +806% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 51.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 6.76M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 6.43M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.